Infectious Diseases (except HIV/AIDS)

Relating in vivo RSV infection kinetics to host infectiousness in different age groups
Ke Li, Louis J. Bont, Daniel M. Weinberger, Virginia E. Pitzer

medRxiv 2024.11.14.24317347; doi: https://doi.org/10.1101/2024.11.14.24317347

Add to Selected Citations
Unexpected Transmission Dynamics in a University Town: Lessons from COVID-19
Erin Clancey, Matthew S. Mietchen, Corrin McMichael, Eric T. Lofgren

medRxiv 2024.01.10.24301116; doi: https://doi.org/10.1101/2024.01.10.24301116

Add to Selected Citations
Monovalent mRNA XBB.1.5 vaccine effectiveness against COVID-19 hospitalization in Quebec, Canada: impact of variant replacement and waning protection during 10-month follow-up
Sara Carazo, Danuta M. Skowronski, Nicholas Brousseau, Charles-Antoine Guay, Chantal Sauvageau, Étienne Racine, Denis Talbot, Iulia Gabriela Ionescu, Judith Fafard, Rodica Gilca, Jonathan Phimmasone, Philippe De Wals, Gaston De Serres

medRxiv 2024.11.13.24317190; doi: https://doi.org/10.1101/2024.11.13.24317190

Add to Selected Citations
Safety and Efficacy of Pemivibart, a Long-Acting Monoclonal Antibody, for Prevention of Symptomatic COVID-19: Interim Results From the CANOPY Clinical Trial
Cameron R. Wolfe, Jonathan Cohen, Kathryn Mahoney, Anna Holmes, Natalia Betancourt, Deepali Gupta, Kazima Tosh, Kristin Narayan, Ed Campanaro, Chloe Katz, Anne-Marie Phelan, Ilker Yalcin, Mark Wingertzahn, Pamela Hawn, Pete Schmidt, Yong Li, Myra Popejoy, the CANOPY Study Group

medRxiv 2024.11.11.24317127; doi: https://doi.org/10.1101/2024.11.11.24317127

Add to Selected Citations
Remoscope: a label-free imaging cytometer for malaria diagnostics
Paul M. Lebel, Ilakkiyan Jeyakumar, Michelle W.L. Khoo, Chris Charlton, Aditi Saxena, Axel Jacobsen, Emorut James, Emily Huynh, William Wu, Greg Courville, Pei-Chuan Fu, Madhura Raghavan, Robert Puccinelli, Olwoch Peter, Grant Dorsey, Phil Rosenthal, Joseph DeRisi, Rafael Gomez-Sjoberg

medRxiv 2024.11.12.24317184; doi: https://doi.org/10.1101/2024.11.12.24317184

Add to Selected Citations
Modeling the SARS-CoV-2 Epidemic and the Efficacy of Different Vaccines Across Different Network Structures
Gregg Hartvigsen, Yannis Dimitroff

medRxiv 2024.11.12.24317192; doi: https://doi.org/10.1101/2024.11.12.24317192

Add to Selected Citations
Cost-effectiveness of routine COVID-19 adult vaccination programmes in England
Matt J. Keeling, Edward M. Hill, Stavros Petrou, Phuong Bich Tran, May Ee Png, Sophie Staniszewska, Corinna Clark, Katie Hassel, Julia Stowe, Nick Andrews

medRxiv 2024.11.08.24316972; doi: https://doi.org/10.1101/2024.11.08.24316972

Add to Selected Citations
Performance characteristics and potential public health impact of improved pre-erythrocytic malaria vaccines targeting childhood burden
Josephine Malinga, Lydia Braunack-Mayer, Thiery Masserey, Matthew Cairns, Sherrie L Kelly, Epke A Le Rutte, Narimane Nekkab, Melissa A Penny

medRxiv 2024.11.12.24317082; doi: https://doi.org/10.1101/2024.11.12.24317082

Add to Selected Citations
A National Active Case-Finding Program for Tuberculosis in Prisons, Peru, 2024
Esther Jung, Valentina A. Alarcón, Wilfredo Santos Solís Tupes, Tatiana Avalos-Cruz, Marco Tovar, Erika Abregu, Max Z. Yang, Jason R. Andrews, Moises A. Huaman

medRxiv 2024.11.08.24317002; doi: https://doi.org/10.1101/2024.11.08.24317002

Add to Selected Citations
Increase of Clostridioides difficile PCR ribotype 002 infection coincides with decreased disease severity in hospitalized patients in the Netherlands
A Baktash, C Harmanus, J Goeman, W Brennan, M Cormican, J Corver, EJ Kuijper, WK Smits

medRxiv 2024.11.11.24316883; doi: https://doi.org/10.1101/2024.11.11.24316883

Add to Selected Citations

Infectious Diseases (except HIV/AIDS)

Pages